Home » BLOG » DoseMe to invest in EMR integration, commercialisation following capital raising

DoseMe to invest in EMR integration, commercialisation following capital raising

DoseMe to invest in EMR integration following capital raising

Medications dose individualisation software developer DoseMe is set to invest in commercialising the product in Australia and integrating it with electronic medical records as it prepares for entry into the US and European markets, following the successful closure of a $2.6 million Series A financing round.

Leave a Reply

Your email address will not be published. Required fields are marked *